ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

Study Explores Reasons Women Avoid Mammograms

February 25, 2011

New Frederick RFP Out May 14; Five contracts To Be Awarded, Each For Five to Seven Years

May 2, 1986

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

October 31, 2003

DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off

June 1, 2001

Two New Communications Contracts Approved

October 18, 1985